This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shreve, M. R.
Right arrow Articles by Investigators for the Epidemiologic Study of Cystic Fibrosis
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shreve, M. R.
Right arrow Articles by Investigators for the Epidemiologic Study of Cystic Fibrosis,

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 1999, p. 753-757, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Impact of Microbiology Practice on Cumulative Prevalence of Respiratory Tract Bacteria in Patients with Cystic Fibrosis

Michael R. Shreve,1,* Steven Butler,2 Haley J. Kaplowitz,2 Harvey R. Rabin,3 Dennis Stokes,4 Michael Light,5 Warren E. Regelmann1 for North American Scientific Advisory Group and Investigators for the Epidemiologic Study of Cystic Fibrosis

University of Minnesota School of Medicine, Minneapolis, Minnesota1; Genentech, Inc., South San Francisco,2 and University of California, San Diego, La Jolla,5 California; Health Sciences Center, University of Calgary, Calgary, Alberta, Canada3; and Vanderbilt University Medical Center, Nashville, Tennessee4

Received 14 September 1998/Accepted 17 November 1998

Investigators participating in the Epidemiologic Study of Cystic Fibrosis project began to collect microbiological, pulmonary, and nutritional data on cystic fibrosis (CF) patients at 180 North American sites in 1994. Part of this study was a survey undertaken in August 1995 to determine microbiology laboratory practices with regard to pulmonary specimens from CF patients. The survey included a section on test ordering, completed by a site clinician, and a section on test performance and reporting, completed by each site's clinical microbiology laboratory staff. Seventy-nine percent of the surveys were returned. There was intersite consistency of microbiology laboratory practices in most cases. The majority of sites follow most of the CF Foundation consensus conference recommendations. There were differences in the frequency at which specimens for culture were obtained, in the use of selective media for Staphylococcus aureus and Haemophilus influenzae, and in the use of a prolonged incubation for Burkholderia cepacia. These variations in practice contribute to prevalence differences among sites and may result in differences in clinical care.

* Corresponding author. Mailing address: Department of Pediatrics, Division of Pulmonary and Critical Care Medicine, University of Minnesota School of Medicine, Box 742, 420 Delaware St. S.E., Minneapolis, MN 55044. Phone: (612) 626-4440. Fax: (612) 624-0696. E-mail: shrev002{at}gold.tc.umn.edu.

Journal of Clinical Microbiology, March 1999, p. 753-757, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R., Gilpin, D. F., McDowell, A., Elborn, J. S. (2008). Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 177: 995-1001 [Abstract] [Full Text]  
  • Harris, J. K., De Groote, M. A., Sagel, S. D., Zemanick, E. T., Kapsner, R., Penvari, C., Kaess, H., Deterding, R. R., Accurso, F. J., Pace, N. R. (2007). Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl. Acad. Sci. USA 104: 20529-20533 [Abstract] [Full Text]  
  • Vergison, A., Denis, O., Deplano, A., Casimir, G., Claeys, G., DeBaets, F., DeBoeck, K., Douat, N., Franckx, H., Gigi, J., Ieven, M., Knoop, C., Lebeque, P., Lebrun, F., Malfroot, A., Paucquay, F., Pierard, D., Van Eldere, J., Struelens, M. J. (2007). National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother 59: 893-899 [Abstract] [Full Text]  
  • Zhou, J., Garber, E., Desai, M., Saiman, L. (2006). Compliance of Clinical Microbiology Laboratories in the United States with Current Recommendations for Processing Respiratory Tract Specimens from Patients with Cystic Fibrosis. J. Clin. Microbiol. 44: 1547-1549 [Abstract] [Full Text]  
  • Campana, S., Taccetti, G., Ravenni, N., Favari, F., Cariani, L., Sciacca, A., Savoia, D., Collura, A., Fiscarelli, E., De Intinis, G., Busetti, M., Cipolloni, A., d'Aprile, A., Provenzano, E., Collebrusco, I., Frontini, P., Stassi, G., Trancassini, M., Tovagliari, D., Lavitola, A., Doherty, C. J., Coenye, T., Govan, J. R. W., Vandamme, P. (2005). Transmission of Burkholderia cepacia Complex: Evidence for New Epidemic Clones Infecting Cystic Fibrosis Patients in Italy. J. Clin. Microbiol. 43: 5136-5142 [Abstract] [Full Text]  
  • Goss, C H, Mayer-Hamblett, N, Aitken, M L, Rubenfeld, G D, Ramsey, B W (2004). Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 59: 955-959 [Abstract] [Full Text]  
  • Miller, M. B., Gilligan, P. H. (2003). Laboratory Aspects of Management of Chronic Pulmonary Infections in Patients with Cystic Fibrosis. J. Clin. Microbiol. 41: 4009-4015 [Full Text]  
  • Johnson, C., Butler, S. M., Konstan, M. W., Morgan, W., Wohl, M. E. B. (2003). Factors Influencing Outcomes in Cystic Fibrosis: A Center-Based Analysis. Chest 123: 20-27 [Abstract] [Full Text]  
  • Ferroni, A., Sermet-Gaudelus, I., Abachin, E., Quesne, G., Lenoir, G., Berche, P., Gaillard, J.-L. (2002). Use of 16S rRNA Gene Sequencing for Identification of Nonfermenting Gram-Negative Bacilli Recovered from Patients Attending a Single Cystic Fibrosis Center. J. Clin. Microbiol. 40: 3793-3797 [Abstract] [Full Text]  
  • Coenye, T., Goris, J., Spilker, T., Vandamme, P., LiPuma, J. J. (2002). Characterization of Unusual Bacteria Isolated from Respiratory Secretions of Cystic Fibrosis Patients and Description of Inquilinus limosus gen. nov., sp. nov.. J. Clin. Microbiol. 40: 2062-2069 [Abstract] [Full Text]  
  • Coenye, T., Vandamme, P., Govan, J. R. W., LiPuma, J. J. (2001). Taxonomy and Identification of the Burkholderia cepacia Complex. J. Clin. Microbiol. 39: 3427-3436 [Full Text]  
  • McMenamin, J. D., Zaccone, T. M., Coenye, T., Vandamme, P., LiPuma, J. J. (2000). Misidentification of Burkholderia cepacia in US Cystic Fibrosis Treatment Centers : An Analysis of 1,051 Recent Sputum Isolates. Chest 117: 1661-1665 [Abstract] [Full Text]  
  • Richau, J. A., Leitão, J. H., Correia, M., Lito, L., Salgado, M. J., Barreto, C., Cescutti, P., Sá-Correia, I. (2000). Molecular Typing and Exopolysaccharide Biosynthesis of Burkholderia cepacia Isolates from a Portuguese Cystic Fibrosis Center. J. Clin. Microbiol. 38: 1651-1655 [Abstract] [Full Text]  
  • Pitulle, C., Citron, D. M., Bochner, B., Barbers, R., Appleman, M. D. (1999). Novel Bacterium Isolated from a Lung Transplant Patient with Cystic Fibrosis. J. Clin. Microbiol. 37: 3851-3855 [Abstract] [Full Text]  
  • LiPuma, J. J., Dulaney, B. J., McMenamin, J. D., Whitby, P. W., Stull, T. L., Coenye, T., Vandamme, P. (1999). Development of rRNA-Based PCR Assays for Identification of Burkholderia cepacia Complex Isolates Recovered from Cystic Fibrosis Patients. J. Clin. Microbiol. 37: 3167-3170 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»